Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferrer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferrer, J.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:2355-2362, 2002
© 2002 by the American Diabetes Association, Inc.

Perspectives in Diabetes

A Genetic Switch in Pancreatic ß-Cells

Implications for Differentiation and Haploinsufficiency

Jorge Ferrer

From the Department of Endocrinology, Hospital Clínic i Universitari, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain

Heterozygous mutations in the genes encoding transcriptional regulators hepatocyte nuclear factor (HNF)-1{alpha} and HNF-4{alpha} cause a form of diabetes known as maturity-onset diabetes of the young (MODY). Haploinsufficiency of HNF-1{alpha} or HNF-4{alpha} results in MODY because of defective function of pancreatic islet cells. In contrast, homozygous null mutations in mouse models lead to widespread and profound gene expression defects in multiple cell types. Thus, it is not surprising that HNF-1{alpha} function is now known to have distinct properties in pancreatic ß-cells. It controls a complex tissue-selective genetic network that is activated when pancreatic cells differentiate, and allows these cells to maintain critical specialized functions. The network contains an indispensable core component formed by a positive cross-regulatory feedback circuit between HNF-1{alpha} and HNF-4{alpha}. This type of circuit configuration can exhibit a switch-like behavior with two stable states. In the default active state, it can serve to perpetuate network activity in differentiated ß-cells. However, the loss of one HNF-1{alpha} or HNF-4{alpha} allele can increase the probability that the feedback circuit is permanently switched off, resulting in decreased expression of all four alleles selectively in ß-cells. Such a model can serve to rationalize key aspects of the pathogenic mechanism in MODY.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
L. W. Harries, J. M. Locke, B. Shields, N. A. Hanley, K. P. Hanley, A. Steele, P. R. Njolstad, S. Ellard, and A. T. Hattersley
The Diabetic Phenotype in HNF4A Mutation Carriers Is Moderated By the Expression of HNF4A Isoforms From the P1 Promoter During Fetal Development
Diabetes, June 1, 2008; 57(6): 1745 - 1752.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Eeckhoute, E. K. Keeton, M. Lupien, S. A. Krum, J. S. Carroll, and M. Brown
Positive Cross-Regulatory Loop Ties GATA-3 to Estrogen Receptor {alpha} Expression in Breast Cancer
Cancer Res., July 1, 2007; 67(13): 6477 - 6483.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. C. Raum, K. Gerrish, I. Artner, E. Henderson, M. Guo, L. Sussel, J. C. Schisler, C. B. Newgard, and R. Stein
FoxA2, Nkx2.2, and PDX-1 Regulate Islet {beta}-Cell-Specific mafA Expression through Conserved Sequences Located between Base Pairs -8118 and -7750 Upstream from the Transcription Start Site
Mol. Cell. Biol., August 1, 2006; 26(15): 5735 - 5743.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
L. W. Harries, S. Ellard, A. Stride, The European MODY consortium, N. G. Morgan, and A. T. Hattersley
Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes
Hum. Mol. Genet., July 15, 2006; 15(14): 2216 - 2224.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
N. E. Rubins, J. R. Friedman, P. P. Le, L. Zhang, J. Brestelli, and K. H. Kaestner
Transcriptional Networks in the Liver: Hepatocyte Nuclear Factor 6 Function Is Largely Independent of Foxa2
Mol. Cell. Biol., August 15, 2005; 25(16): 7069 - 7077.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. N. Weedon, K. R. Owen, B. Shields, G. Hitman, M. Walker, M. I. McCarthy, A. T. Hattersley, and T. M. Frayling
A Large-Scale Association Analysis of Common Variation of the HNF1{alpha} Gene With Type 2 Diabetes in the U.K. Caucasian Population
Diabetes, August 1, 2005; 54(8): 2487 - 2491.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. Boulias and I. Talianidis
Functional role of G9a-induced histone methylation in small heterodimer partner-mediated transcriptional repression
Nucleic Acids Res., November 18, 2004; 32(20): 6096 - 6103.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. N. Weedon, K. R. Owen, B. Shields, G. Hitman, M. Walker, M. I. McCarthy, L. D. Love-Gregory, M. A. Permutt, A. T. Hattersley, and T. M. Frayling
Common Variants of the Hepatocyte Nuclear Factor-4{alpha} P2 Promoter Are Associated With Type 2 Diabetes in the U.K. Population
Diabetes, November 1, 2004; 53(11): 3002 - 3006.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
S. A. Hinke, K. Hellemans, and F. C. Schuit
Plasticity of the {beta} cell insulin secretory competence: preparing the pancreatic {beta} cell for the next meal
J. Physiol., July 15, 2004; 558(2): 369 - 380.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
J. Eeckhoute, P. Formstecher, and B. Laine
Hepatocyte Nuclear Factor 4{alpha} enhances the Hepatocyte Nuclear Factor 1{alpha}-mediated activation of transcription
Nucleic Acids Res., May 11, 2004; 32(8): 2586 - 2593.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. I. McCarthy
Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification
Hum. Mol. Genet., April 1, 2004; 13(suppl_1): R33 - R41.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
D. T. Odom, N. Zizlsperger, D. B. Gordon, G. W. Bell, N. J. Rinaldi, H. L. Murray, T. L. Volkert, J. Schreiber, P. A. Rolfe, D. K. Gifford, et al.
Control of Pancreas and Liver Gene Expression by HNF Transcription Factors
Science, February 27, 2004; 303(5662): 1378 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. A. Maestro, S. F. Boj, R. F. Luco, C. E. Pierreux, J. Cabedo, J. M. Servitja, M. S. German, G. G. Rousseau, F. P. Lemaigre, and J. Ferrer
Hnf6 and Tcf2 (MODY5) are linked in a gene network operating in a precursor cell domain of the embryonic pancreas
Hum. Mol. Genet., December 15, 2003; 12(24): 3307 - 3314.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Vilsboll, F. K. Knop, T. Krarup, A. Johansen, S. Madsbad, S. Larsen, T. Hansen, O. Pedersen, and J. J. Holst
The Pathophysiology of Diabetes Involves a Defective Amplification of the Late-Phase Insulin Response to Glucose by Glucose-Dependent Insulinotropic Polypeptide--Regardless of Etiology and Phenotype
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4897 - 4903.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Eeckhoute, E. Moerman, T. Bouckenooghe, B. Lukoviak, F. Pattou, P. Formstecher, J. Kerr-Conte, B. Vandewalle, and B. Laine
Hepatocyte Nuclear Factor 4{alpha} Isoforms Originated from the P1 Promoter Are Expressed in Human Pancreatic {beta}-Cells and Exhibit Stronger Transcriptional Potentials than P2 Promoter-Driven Isoforms
Endocrinology, May 1, 2003; 144(5): 1686 - 1694.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. M.S. Mitchell, M. N. Weedon, K. R. Owen, B. Shields, B. Wilkins-Wall, M. Walker, M. I. McCarthy, T. M. Frayling, and A. T. Hattersley
Genetic Variation in the Small Heterodimer Partner Gene and Young-Onset Type 2 Diabetes, Obesity, and Birth Weight in U.K. Subjects
Diabetes, May 1, 2003; 52(5): 1276 - 1279.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.